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Since the 1970s when the first case of the human immunodeficiency virus was detected, there 
have been many controversies since the topic is a sensitive one. Since then, it has been classi-
fied as a global epidemic having claimed millions of people so far. Globally, at least 75 mil-
lion people have been infected with the virus and about 32 million people have died due to 
the epidemic. However, due to advancement in treatment, nowadays HIV has been consid-
ered a manageable condition, but if appropriate interventions are not initiated early, it can 
advance to acquired immunodeficiency syndrome leading to opportunistic diseases, and hence 
death. Although HIV testing is crucial for prevention and early diagnosis, late diagnosis still 
remains an area of concern in many countries, Finland being one of them. 
The goal of this study was to increase awareness of accessibility and the use of HIV testing 
service in Finland to reduce late diagnosis. The objective of this study was to seek evidence 
on factors that contribute to low HIV testing service uptake in Finland, and factors that when 
put into practice can lead to increased HIV testing service uptake. The research questions for 
this study were finding out the factors that act as barriers to HIV testing service uptake in 
Finland, and the factors that when put into practice can lead into increased HIV testing ser-
vice uptake in Finland. 
 
Integrative literature review was used as a method for this study. Data search was conducted 
in May 2020 by using four databases. Ten qualitative and quantitative studies with varying de-
signs were included after data evaluation was done. Critical Appraisal Skills Program for qual-
itative studies and systematic reviews and STROBE for the cross-sectional survey were used to 
assess the quality of included articles. Evidences from primary articles were extracted and 
key barriers and facilitators to HIV testing were identified, categorized, summarized, and or-
ganized in an evidence table. 
 
Identified barriers included lack of knowledge and awareness of HIV, lack of HIV risk percep-
tion, lack of access to HIV testing, providers’ time constraints, communication problem, and 
fear and stigma. In addition, the identified facilitators included increasing knowledge and 
awareness about HIV, integrating HIV testing services into primary healthcare and normalizing 
testing, and access to testing. 
 
HIV testing is a crucial step for prevention and early diagnosis of HIV. Therefore, recognizing 
the key barriers and facilitators to HIV testing is essential to increase population testing up-
take capacity. The findings can be used as a tool to facilitate creation of effective strategies, 
aimed at increasing HIV testing service uptake, and decreasing the number of infected people 
who are unaware of their status.  
 
 
 
 
 
Keywords: Human immunodeficiency virus (HIV), testing, barriers, facilitators, integrative lit-
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1 Introduction 
Since the 1970s when the first case of the human immunodeficiency virus (HIV) was detected, 
there have been many controversies since the topic is a sensitive one (AIDS Virus Education 
Research Trust 2019). Since then, it has been classified as a global epidemic having claimed 
millions of people so far. Globally, at least 75 million people have been infected with the vi-
rus and  about 32 million people have died due to the epidemic. (World Health Organization 
2018). 
However, due to advancement in treatment, nowadays HIV has been considered a managea-
ble condition, but if appropriate interventions are not initiated early, HIV can advance to ac-
quired immunodeficiency syndrome (AIDS) leading to opportunistic diseases, and hence death. 
HIV testing remains the only means to providing early diagnosis to ensure that appropriate 
treatments are started early for those found to have been infected with the virus. To add, 
early and regular HIV testing and early diagnosis will lead to preserving the quality of life of 
those infected when treatment is started early. Early and frequent HIV testing will also en-
hance the reduction of the number of undiagnosed cases hence preventing transmission of the 
HIV virus (Public Health Agency of Canada 2014). 
Late diagnosis remains an area of concern in many countries, Finland being one of them. The 
United Nations’ (UN) 90-90-90 target to end HIV epidemic by 2020 aim in achieving 90% of 
people living with HIV knowing their status, 90% of all people diagnosed with HIV receive 
treatments, and 90% of all people receiving treatment will be virally suppressed. Therefore, 
HIV testing is crucial to achieving the first “90” (Joint United Nations Programme on HIV and 
AIDS 2014). Globally, in 2018 79% of people living with HIV knew their status, among those 
who knew their status 78% were accessing treatments, and among those accessing treatments 
87% were virally suppressed (UNAIDS 2019). By 79% of people living with HIV knowing their 
status, this shows much has been achieved globally, but still there is a gap remaining to 
achieving the 90% target. 
In Finland, low testing service uptake remains a problem. Finnish Institute for Health and 
Welfare (Terveyden ja hyvinvoinnin laitos 2018) estimated that, there were about 400 people 
in Finland living with HIV but are unaware of their infection, with most cases being diagnosed 
in the late stage when HIV has already progressed to AIDS. Moreover, an expert from Helsinki 
HIV clinic also confirmed that late diagnosis is an issue of concern in Finland because there is 
low uptake of HIV testing in Finnish population. This was during a meeting with one of the au-
thors at the beginning of 2018. Therefore, authors decided to conduct a study to find out the 
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factors that contributes to low HIV testing service uptake in Finland (barriers), and factors 
that when put into practice can lead to increased HIV testing service uptake (facilitators). 
2 Human immunodeficiency virus and acquired immunodeficiency syndrome 
Human Immunodeficiency Virus (HIV) is a type of virus that affects immune system of the in-
dividuals by destroying and deforming immune cells, thus making infected persons loose abil-
ity to fight against infections, hence becoming immunodeficient slowly by slowly. The infec-
tion of HIV is determined by measuring CD4 cell count, a typical way of measuring immune 
function of the body. (WHO 2019). When there are not enough CD4 cells in the bloodstream, 
the body become more susceptible to microorganisms which it used to fight off easily before, 
making infections that normally causes mild illnesses a severe problem (Olalla, Reyes and 
Caylà 2012). There are two species of HIV that infect humans. HIV-1 has many strains and re-
sponsible HIV-related diseases and its predominant virus worldwide. HIV-2, which is less trans-
mittable and uncommon, is mainly confined in West Africa but can also be found in other 
countries with have link to West Africa (AVERT 2019). Over decades, efforts to develop a suit-
able vaccine for HIV has not been successful due to the reason that, HIV has ability to modify 
its structure (Olalla et al. 2012). On the other hand, Acquired Immunodeficiency Syndrome 
(AIDS) is the advanced stage of HIV infection and can take 2-15 years to develop (WHO 2019). 
AIDS is associated with manifestation of illnesses such as some types of cancer, tuberculosis, 
candidiasis, pneumonia, and many other opportunistic infections (AVERT 2019). 
HIV is transmitted through sexual contacts, infected blood, through breast milk from mother 
to child, and the virus can be transmitted from mother to child during childbirth (AVERT 
2019). Some more common daily contacts such as kissing, hugging, shaking hands, sharing 
food and water do not pose any risk of being infected with HIV (WHO 2019). Risk factors are 
unprotected vaginal or anal sex, multiple sex partners, sharing contaminated needles or sy-
ringes, having another sexually transmitted disease such as syphilis and chlamydia and acci-
dental needle sticks especially among healthcare workers (WHO 2019). 
HIV can be prevented by taking various precautions such as practicing safe sex by for example 
using condom, seeking treatment early for other sexually transmitted diseases such as syphilis 
and chlamydia, use of clean needles among healthcare workers as well as following hospital 
guidelines in case of needle stick, reducing the number of sex partners and abstaining (AVERT 
2019). Other methods to prevent HIV transmission are use of Pre-exposure prophylaxis (PrEps) 
for those who are HIV negative and are at risk of contracting HIV, and post-exposure prophy-
laxis (PEPS) in case of potential exposure and treatment has to be started within 72 hours of 
exposure. However, HIV testing remains the main HIV preventive measure since it is the only 
way to know whether a person is infected or not, and it is very crucial in cutting transmission 
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chain. Testing provides an opportunity to those who test HIV negative to choose to remain 
negative, and to those who test HIV positive to start a treatment regime, hence preventing 
further transmission (Centres for Disease Control and Prevention 2019). 
2.1 Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome in global 
context 
Statistics released by Joint United Nations Programme on HIV and AIDS (UNAIDS) 2019, esti-
mated that by the end of 2018, there were 37.9 million people living with HIV worldwide. Of 
all the victims, 36.2 million were adults and 1.7 million children of under 15 years of age. In 
the same report, it is outlined that 770 000 people died out of AIDS related complications in 
only 2018, and 8.1 million people were living with the virus unknowingly. Out of all people 
living with HIV in 2018, 79% knew their status, 62% had access to treatment and 53% were vi-
rally suppressed. The 2018 HIV and AIDS regional statistics are represented in Table 1. 
Table 1: Regional statistics of HIV and AIDS (UNAIDS 2019) modified by authors 
2.2 Human immunodeficiency virus and acquired immunodeficiency syndrome in finland 
In Finland, first case of HIV was found in 1980 and since then the number of new HIV infec-
tions has gradually increased yearly, with the sexual contacts being the most common way of 
transmitting HIV infections (THL 2013). According to the report of Finnish Institute for Health 
and Welfare (2013), by 2012 altogether 300 people had died of AIDS in Finland. In the year 
2000 to 2011, AIDS related diseases remain the main cause of death in the records of Helsinki 
HIV clinic, with AIDS related deaths totaling up to 43% of all 83 cases while AIDS malignancies 
 
Region  
People living 
with HIV 2018  
New HIV infec-
tions in 2018 
AIDS related 
death in 
2018 
People access-
ing treatment 
2018 
Eastern and 
Southern Africa 
20.6 million 800 000 310 000 13.8 million 
Asia and the Pa-
cific 
5.9 million 310 000 200 000 3.6 million 
Western and Cen-
tral Africa 
5.0 million 280 000 160 000 2.6 million 
Latin America 1.9 million 100 000 35 000 1.2 million 
The Caribbean 340 000 16 000 6700 187 000 
Middle East and 
North Africa 
240 000 20,000 8400 78 000 
Eastern Europe 
and Asia 
1.7 million 150 000 38 000 684 000 
Western and Cen-
tral Europe and 
North America 
2.2 million 68 000 13 000 1.7 million 
Global Total 37.9 million 1.7 million 770 000   23.3 million 
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causing 15% and cardio-vascular diseases 10% of all deaths (Hanttu 2017). In the latest statis-
tics, by 24th of May 2020, 4239 case of HIV infections in total have been reported in Finland 
since the first case 1980 with 149 cases being reported only in 2018 and 43 cases between 1st 
of January and 24th of May 2020 (THL 2020). 
In Finland, much effort has been put to tackle with HIV/AIDS through prevention and treat-
ment schemes. The Finnish government has made HIV treatment and care for people living 
with HIV free and HIV screening is free for every citizen. (Hanttu 2017). Free HIV clinics have 
been established in cities like Helsinki, Oulu, and Tampere. HIV clinics deals with free HIV 
testing, counselling, and providing support to those affected. Sex educational campaigns have 
been going on in Finland for years. Since 2007, compulsory sexual reproductive health educa-
tion has been included in the curriculum of all secondary schools and vocational schools. 
(Korhonen, Kylmä, Houtsonen, Välimäki & Suominen 2012; European Centre for Disease Pre-
vention and Control 2012). Despite all these efforts Finnish government has made to provided 
HIV & AIDS preventive and treatments services, late diagnosis remains a great problem in Fin-
land as well as in other European countries and there is increasing number of people living 
with HIV virus unknowing. According to European Centre for Disease Prevention and Control 
(2015), 1 in 7 people in EU/EEA are infected with HIV and they do not know they are infected. 
However, this hinder early diagnosis and treatment of sexually transmitted diseases HIV being 
one of them and may continue the chain of transmission (Haapa 2018). 
Finnish Institute for Health and Welfare (2018) estimated that, there are about 400 people in 
Finland living with HIV virus but are unaware of infection, with most cases being diagnosed in 
the late stage when it has progressed to AIDS. At this stage, the body immune system is al-
ready weak thus weakening the effectiveness of the treatment and increasing chances of con-
tracting more opportunistic infections (THL 2013). Furthermore, an expert from Helsinki HIV 
clinic also confirmed that late diagnosis is an issue of concern in Finland because there is low 
uptake of HIV testing in Finnish population. This was during a meeting with one of the authors 
at the beginning of 2018. Therefore, authors decided to conduct a study to find out the fac-
tors that contributes to low HIV testing service uptake in Finland (barriers), and factors that 
when put into practice can lead to increased HIV testing service uptake (facilitators). 
3 Goals, Objectives, and Research Questions 
The goal of this integrative literature review is to increase awareness of accessibility and the 
use of HIV testing service in Finland to reduce late diagnosis. The objective of this study is to 
seek evidence on factors that contribute to low HIV testing service uptake in Finland, and fac-
tors that when put into practice can lead to increased HIV testing service uptake. The factors 
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can in turn be used as a tool to facilitate creation of effective strategies aimed at increasing 
HIV testing service uptake in Finland. 
The research questions for the integrative literature review: 
1. What are the factors that act as barriers to HIV testing service uptake in Finland? 
2. What are the facilitators that when put into practice can lead into increased HIV testing 
service uptake in Finland? 
4 Study method and data search process 
4.1 Study method 
Integrative literature review was used as a study method. An integrative literature review is a 
method that provides a broader understanding of a phenomenon or healthcare problem by re-
capitulating past empirical or theoretical literature (Whittemore & Knafl, 2005). Therefore, 
the reason for choosing integrative literature review as a method for this study was the pre-
sumption that barriers and facilitators to HIV testing service uptake have not been systemati-
cally studied in Finland. 
An integrative literature review synthesizes knowledge and facts using quantitative and quali-
tative methods including critical analysis, knowledge synthesis of topic, conceptual and logi-
cal reasoning and used as a catalyst research for further study. The integrative review nar-
rates the topic by critically analyzing of the literature. This includes the origin and archive of 
the particular topic. (Whittemore, Chao, Jang, Minges & Park 2014). The integrative review 
methodology key prerequisite is a well thought work with a comprehensive detailed, conclu-
sion of which may be a significant contribution to a certain body of knowledge and, conse-
quence, to practice and research. (Russell 2005). 
In Addition, an integrative review literature review synthesizes the evidence from numerous 
qualitative and quantitative studies from a holistic conceptualization and critical analysis, 
synthesis of the literature to date. Integrative reviews provide and may offers valuable new 
perspectives for proper new understanding on the topic. (Torraco 2005). The integrative re-
view method is an approach which allows of the diverse formative composition of multiple 
methodologies which are experimental and non-experimental research studies. (Whittemore 
& Knafl, 2005). 
To rationalize of the approach to acquire peer-reviewed studies which have applied the meth-
odology, Whittemore (2005) conceptualizes the integrative review as occurring in five stages 
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modified by Cooper’s (2008). The stages are (1) problem formulation, (2) data collection or 
literature search, (3) evaluation of data, (4) data analysis, and (5) interpretation and presen-
tation of results. 
 
Figure 1: Five stages of integrative literature review from Whittemore (2005) modified by the 
authors 
4.2 Inclusion and exclusion criteria 
Defining inclusion and exclusion criteria is crucial in research work. With mutual agreement, 
the inclusion and exclusion criteria were outlined before the commencement of data search. 
Data published between 2015 and 2020 were included in the study. The reason for deciding to 
use literatures published between 2015 and 2020 is because the topic of barriers and facilita-
tors to HIV testing has been continuously studied globally. Therefore, to get the latest and up 
to date information, the authors saw the need to limit the data search by the year of publica-
tion. Peer review literatures published in English language were included in the study. There 
was no population limit. The inclusion and exclusion criteria table, and study implementation 
timetable are presented in the Table 2 and 3, respectively. 
 
Inclusion criteria  Exclusion criteria 
Literatures published in English Other languages 
Literatures published between 2015-2020 Literatures published before 2015 
Peer reviewed journal and articles, original 
publications, peer reviewed conference 
publications, guidelines/recommendations 
on HIV testing service uptake. 
Textbooks, pro-gradu thesis, newspapers, 
narrative literature reviews, case reports 
Contents focusing on HIV testing/ HIV test-
ing service uptake/barriers/facilitators 
Contents not focusing on HIV testing/ HIV 
testing service uptake/barriers/facilitators 
All population included  
Table 2: Inclusion and exclusion criteria 
PROBLEM 
IDENTIFICATION
LITERATURE 
SEARCH
DATA 
EVALUATION
DATA 
ANALYSIS
PRESENTATION
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Stages Timetable 
Planning stage  
Subject choosing and method and presenting the topic to the 
tutor teacher 
Thesis plan 
 
November 2019 
 
November 2019-April 2020 
Implementation stage 
Literature review & data collection  
Data evaluation  
Data analysis, results, and conclusion 
 
April- May 2020 
May 2020 
May 2020 
Final stage  
Thesis presentation 
Publication of thesis 
 
Early June 2020 
June 2020 
Table 3: Timetable 
4.3 Data search process and review 
Data search was conducted in May 2020. After thorough discussion and guidance from the 
school librarian, writers searched data published in western countries between 2015 and 2020 
using four electronic databases namely, Cumulative Index to Nursing and Allied Health Litera-
ture (CINAHL), PubMed, ProQuest Central and Cochrane Library. The search terms and data-
bases used in data search process are illustrated in Figure 2. 
 
Figure 2: Data search from databases 
 
In electronic data search a total 626 articles were identified. After screening for duplicate, 
215 potential references remained. Title and abstract were further screened for relevancy 
and a total of 117 potential references remained. Next full text was screened narrowing po-
tential articles to 52. Finally, the full text articles were assessed for inclusion and exclusion 
criteria and quality and a total of 42 articles were excluded, mainly for not fulfilling inclusion 
and exclusion criteria. The included references in the study were 10 and out of them, four (4) 
Pubmed
•HIV OR "Human 
immunodeficiency 
virus" AND testing 
OR screening AND 
Barriers OR 
Hindrances AND 
Facilitators OR 
Predictors
CINAHL
•HIV OR "Human 
immunodeficiency 
virus" AND testing 
OR screening AND 
Barriers AND 
Facilitators 
Cochrane
•HIV OR "Human 
immunodeficiency 
virus" AND testing 
OR screening AND 
Barriers AND 
Facilitators 
Proquest
•HIV OR "Human 
immunodeficiency 
virus" AND testing 
OR screening AND 
Barriers AND 
Facilitators 
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were qualitative studies, five (5) systematic reviews and one (1) cross-sectional analysis sur-
vey. All the included studies were conducted between 2015 and 2020 (n=10). The settings of 
the studies were all in Western countries: United States of America, (n=6), United Kingdom 
(n=1), Canada (n=1), Australia (n= 1), Europe (n=1). No study was found from Finland. In-
cluded studies were saved into RefWorks. The data search process is represented in Figure 3. 
 
 
 
Figure 3: Identification, retrieval, and inclusion of relevant studies (PRISMA 2015) 
Potential references (n=626) 
PubMed (n=327) 
CINAHL (n=125) 
ProQuest (n=74) 
Cochrane (n=100) 
 
Duplicated  screened 
Removed: 411 
Potential references (n=215) 
Potential references (n=117) 
Potential references (n=52) 
10 references included 
Systematic reviews (n=5) 
Qualitative studies (n=4) 
Cross-sectional  
analysis survey (n =1) 
 
Title/abstract screened 
Removed: 98 
 
Full text screened 
Removed: 65 
Full text assessed for inclu-
sion criteria and quality 
Removed: 42 
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4.4 Quality assessment 
It is obvious for integrative reviews to have multiple study designs which can make data eval-
uation process difficult (Whittemore & Knafl, 2005). Therefore, to carefully assess the quality 
of the studies, appropriate data assessment tools are needed. To assess the quality of the in-
cluded studies, the authors used two quality assessment tools. To assess the quality of quali-
tative studies and systematic reviews, Critical Appraisal Skill Programme (CASP) checklist was 
used. CASP provide a variety of checklists for different study designs which help to systemati-
cally assess the trustworthiness, relevance, and results of primary data and were originally 
developed to be used as educational pedagogical tools, as part of a workshop setting (CASP 
2018). To assess the quality of quantitative study STROBE which is a tool developed for im-
proving and strengthening the reporting of observational studies in epidemiology was used 
(Vandenbroucke et al. 2014). 
Checklist (A) adapted from CASP was used to assess the quality of qualitative studies (appen-
dix 1). Checklist (B) applied from CASP was used to assess the quality of systematic reviews 
(appendix 2). Checklist (C) applied from STROBE was used to assess quality of cross-sectional 
analysis survey (appendix 3). Questions were answered as ‘Yes’, ‘Partially’, ‘No’ and the au-
thors also assigned numerical numbers to each answer as ‘Yes=2’, ‘Partially=1’, ‘No=0’ to 
have uniformity in the quality assessment of the included studies. The assessment checklist 
forms for systematic and qualitative studies contained 10 questions respectively, while the 
assessment checklist form for cross-sectional analysis survey contained 22 questions.  
In assessment of the quality of the studies, scoring is usually used. For qualitative and system-
atic reviews, total scores of 20 were calculated for each paper and were graded as high qual-
ity (score=16-20), moderate quality (score=10–15) or low quality (score=1–9). For Cross-sec-
tional analysis survey total scores of 44 were also graded as high quality(score=32-44), moder-
ate quality (score=20-31) and low quality (score=1-19). The quality of systematic reviews 
(n=5), was high, scoring from 16 to 20 out of total score of 20 (appendix 3). The quality of 
qualitative studies (n=4), three were of high-quality scoring from 18 to 20 out of 20 and one 
was of moderate quality scoring 14 out of 20 (appendix 2). The cross-sectional analysis survey 
(n=1), was of high-quality scoring 40 out of 44 (appendix 4). 
4.5 Data analysis 
In this study, data analysis was carried out using the methodology applied from Whittemore 
and Knafl (2005). The methodology entails four stages which are data display, data compari-
son, data reduction and finally drawing conclusion and verification. The Figure 4. below rep-
resent stages of data analysis process. 
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Figure 4: Integrative data analysis process from Whittemore and Knafl (2005) modified by au-
thors. 
Firstly, data was retrieved from primary articles where authors read the articles both individ-
ually and together and outlined and noted down the sentences that answered research ques-
tions which are, ‘What are the factors that act as barriers to HIV testing service uptake in Fin-
land ?’ and ‘What are the facilitators that when put into practice can lead into increased HIV 
testing service uptake in Finland ?’. The characteristic of the studies included were compiled 
into a table (appendix 1). Data reduction was then done by reading the articles again and 
again to identify the key barriers and facilitators in each study. The identified key barriers 
and facilitators were reviewed and categorized, and the key findings were summarized and 
organized in an evidence Table 4. to ease interpretation of the results and drawing the con-
clusion. 
5 Results 
Overall, 10 studies on barriers and facilitators to HIV testing were identified and included for 
the review. The majority of these were American, while smaller number were from European 
countries, Canada, and Australia. No literatures were found from Finland. After reviewing the 
included literatures, numerous barriers and facilitators to HIV testing were identified. The 
studies assessed, focused mostly on patients/clients, providers, and/or organizational barriers 
and/or facilitators to HIV screening/testing. 
 
Barriers Explanation 
Lack of HIV risk percep-
tion 
• Patient believe not having risk of contracting HIV in-
fection, because he/she is not engaging in HIV risk 
behaviours or believe residing in a low prevalence HIV 
country prevent risk of contracting the infection 
• Providers’ assume/believe risk of acquiring HIV 
among his/her patients is low or do not exist or as-
sume since HIV prevalence in his/her region of prac-
tice is low, then his/her patients have no/low risk. 
Lack of knowledge and 
awareness of HIV 
• Patient lacking information about HIV or are not 
aware of how and where to get testing services. 
Data Display Data Comparison Data Reduction
Drawing Conclusion 
& Verification
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• Provider lacking experience on delivering test results. 
Also not knowing consent procedure and recommen-
dation for HIV testing. 
Communication problems • Patient feeling uncomfortable discussing openly 
about sexual health issues or may not know how to 
initiate a conversation about their sexuality with 
healthcare providers. 
• Provider feeling uncomfortable discussing sexuality of 
patient and may lack communication skills on how to 
initiate discussion on sexual practices with their pa-
tients. 
Fear and stigma • Patient fear of positive result, discrimination/aban-
donment by the family and community. 
• Fear of being stigmatized. 
lack of access to testing • Inconvenient testing location & testing hours of oper-
ation may hinder people going for testing.  
• Having to buy self-testing kit can hinder from self-
testing. 
• Language barriers, or an inability to access a variety 
of testing services that are typically available. 
Providers time constraints • Due to competing priorities healthcare providers may 
lack time for HIV testing and pre counselling. 
Facilitators Explanation 
Increasing knowledge and 
awareness 
• Providing patient-centred education through public 
campaigns to increase population HIV awareness, 
streamline HIV discussions and counselling using for 
example popular public tv stations, providing educa-
tional materials written in simple understandable lan-
guage. 
• Provision of provider-centred specific training and 
practical tools need to calculate HIV risk score. Im-
proved provider-patient communication skills 
Integrating HIV services 
and normalizing testing 
• Integrating HIV testing service into primary 
healthcare and making test a routine clinical activity 
to reduce stigma and fear associated with HIV. 
• Providing and administering HIV test unless patient 
declines 
Access to testing • Favourable location of service point and accessible. 
Flexible testing hours 
• Providing self-testing kit for free/at low cost, with 
clear usage guideline 
Figure 5: Description of barriers and facilitators 
5.1 Barriers 
5.1.1 Lack of HIV risk perception 
Lack of HIV risk perception emerged as a common barrier to HIV screening. Four studies out 
of ten outlined lack of HIV risk perception as a barrier (Tan & Black 2018; Traversy, Austin, 
Ha, Timmerman & Gale-Rowe 2018; Leblanc, Flores & Barroso 2016; Youssef, Cooper, 
Delpech, Davies & Wright 2017). Factors such as patients/clients not engaging in HIV risk be-
haviours or believing residing in a low prevalence HIV region exempt them from risk of 
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contracting HIV infection were outlined in one study (Traversy et al. 2018). A qualitative 
meta-synthesis study conducted in USA outlined that lack of HIV risk perception was found to 
have connection with fear of screening (Leblanc et al. 2016). In the systematic review con-
ducted by Youssef et al. (2017), among people aged 50 years and above, out all included 
studies, five pointed HIV was perceived as a young person’s disease and not feeling being part 
of a high-risk group. Healthcare Providers assuming or believing risk of acquiring HIV among 
his/her patients is low or do not exist acted as barrier to recommending HIV test to their pa-
tients/clients (Leblanc et al. 2016; Tan & Black 2018; Traversy et al. 2018). 
5.1.2 Lack of knowledge and awareness of HIV 
Lack of knowledge and awareness about HIV evolved in almost all included studies. Patient 
lacking information about HIV or not aware of how and where to get testing services was 
mentioned in seven studies (Beach, Greene, Lindeman, Johnson, Adames, Thomann, Washing-
ton & Philips 2018; Pharr, Lough & Ezeanolue 2015; Mathews, Ferley, Conserve, Knight, 
Le’Marus, Blumberg, Rennie & Tucker 2020; Tan & Black 2018; Traversy et al. 2018; Leblanc 
et al. 2016; Youssef et al. 2017). Also lack of knowledge on usage of self-testing kit or not 
aware of availability was associated with low testing late (Mathews et al. 2020). Several bar-
riers to routine HIV screening related to healthcare providers’ knowledge were identified in 
most of the included studies. For instance, lack of knowledge about HIV testing recommenda-
tions and guidelines, difficulties in using HIV risk indictor tools or not aware of the tools, lack 
of experience in delivering test results and unaware of consent procedure (Deblonde, 
Dominique, Loos, Boffin, Sasse, Nöstlinger & Supervie 2018; Beach et al. 2018; Pharr et al. 
2015; Tan & Black 2018; Mathews et al. 2020; Traversy et al. 2018; Leblanc et al. 2016; 
Youssef et al. 2017). 
5.1.3 Discomfort and Communication problems 
Most of included studies identified, lack of comfort discussing about sexual health issues as a 
barrier to routine testing in both patients and providers (Pharr et al. 2015; Tan & Black 2018; 
Deblonde et al. 2018; Mathews et al. 2020; Traversy et al. 2018; Leblanc et al. 2016; Youssef 
et al. 2017). Patient feeling uncomfortable discussing openly about sexual behaviours/ health 
issues or not knowing how to initiate discussion about their sexual issues and concerns with 
healthcare providers act as a barrier to HIV testing (Traversy et al. 2018). Providers feeling 
uncomfortable discussing sexual behaviours/health issues with their patients, lack of inter-
personal communication skills on how to initiate discussion on sexual practices with their pa-
tients, lack of skill on how to deliver the test result may alter their proactiveness in offering 
HIV test (Tan & Black 2018; Leblanc et al. 2016; Youssef et al. 2017; Deblonde et al. 2018). 
Language barrier and lack of cultural-sensitive sexual counselling skills can deter provider 
from offering HIV test (Deblonde et al. 2018). 
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5.1.4 Fear and stigma 
In a study conducted in Canada (Traversy et al. 2018), found that patient fear of potential 
positive result and concern of confidentiality/not trusting provider may hinder them from 
seeking HIV test. Similarly, a study done in USA (Pharr et al. 2015) to identify the barriers and 
facilitators to HIV testing experienced by young men having sex with men (MSM), fear of posi-
tive result and rejection from family members/community was mentioned by many partici-
pants as a hindrance to HIV testing. HIV related stigma and discrimination may prevent people 
from seeking HIV testing and healthcare providers from suggesting HIV test to their patients. 
In Pharr et al. (2015) study, stigmatizing and discriminative beliefs like HIV is a gay disease, 
was mentioned by study participants as a hindrance to seeking HIV testing and related ser-
vices. 
5.1.5 Lack of access to HIV testing 
Inconvenient and limited testing locations, where testing centres are in hidden locations mak-
ing it hard to locate or being in extremely open places may rise confidentiality issues, thus 
hindering people from going for HIV testing. Inconvenient testing hours of operation may hin-
der people from going for testing too. (Traversy et al. 2015; Leblanc et al. 2016). Converging 
HIV testing service only in particular centres like HIV clinics or sexual health clinics can hinder 
people from seeking testing service for fear of being recognized and facing discrimination 
(Tan & Black 2018). Therefore, Tan & Black (2018) recommends integration of HIV testing into 
primary healthcare routine general activities. Parental consent for under 18 years was out-
lined in one study as a factor that can hinder timely and frequent access to HIV testing (Pharr 
et al. 2015). Having to buy self-testing kit can hinder people from self-testing (Pharr et al. 
2015). Language barriers can create inability to access variety of testing services that are typ-
ically available (Traversy et al. 2015). 
5.1.6 Providers time constraints 
Lack of time and competing priorities were frequently mentioned by health care providers as 
a reason for them not testing (Traversy et al. 2015; Deblonde et al. 2018; Youssef et al. 2017; 
Tan & Black 2018.). Unfamiliarity with consent procedure, pre-counselling, or post-counsel-
ling procedure, HIV testing local guidelines may make provider feel procedure being more 
time consuming thus opting not to offer HIV test (Traversy et al. 2015; Youssef et al. 2017). 
Lack of enough health care providers leading to overburdening number of tasks, may deter 
offering routine HIV testing (Deblonde et al. 2018). 
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5.2 Facilitators 
5.2.1 Increasing knowledge and awareness 
Providing patient-centred education through public campaigns to increase population HIV 
awareness, streamline HIV discussions and counselling using for example, popular public tv 
stations, interactive HIV education program and providing educational materials written in 
simple understandable language about benefits of testing and services for HIV, may lead to 
improved HIV testing uptake (Aung, Blondell & Durham 2017; Traversy et al. 2015; Leblanc et 
al. 2016). Provision of provider-centred specific training (trainings that equip providers with 
skill to engage clients in discussions about sexual health and skills to encourage and reinforce 
the importance of knowing own’s HIV status), will not only encourage providers to proactively 
offer testing, but it will also build their confidence (Deblonde et al. 2018; Leblanc et al. 
2016; Traversy et al. 2015). Educating providers on how to use practical tools needed to cal-
culate HIV risk score has been outlined as an important HIV testing facilitator (Deblonde et al. 
2018; Leblanc et al. 2016). Increased knowledge and awareness about HIV, was associated 
with decrease in fear, stigma and discrimination in a qualitative study conducted among 
young MSM by Beach et al. (2018). 
5.2.2 Integrating HIV services and normalizing testing 
Integrating HIV testing service into primary healthcare and making screening a routine clinical 
activity to reduce stigma and fear associated with HIV was encouraged in various included 
studies (Deblonde et al. 2018; Leblanc et al. 2016; Traversy et al. 2015). Healthcare providers 
offering and administering HIV test unless patient declines (opt-out testing). The studies con-
ducted by Youssef et al. (2017) and Traversy et al. (2015), indicates that when health care 
providers suggested HIV test to their patients, they were likely willing to be tested. Similarly, 
up-to date and clear flexible policies may ease providers’ fear of testing (Youssef et al. 
2017). 
5.2.3 Access to testing 
Favourable and accessible testing service point widely distributed in various locations and 
convenient testing hours in testing centres may encourage uptake of HIV testing service 
(Traversy et al. 2015; Leblanc et al. 2016). Decentralizing testing beyond facility-based sites 
(not only in HIV clinic and sexual health clinic, but in all healthcare settings) may eliminate 
fear of being recognized and facing discrimination (Tan & Black 2018). Therefore, Tan and 
Black (2018) recommends integration of HIV testing into primary healthcare routine general 
activities to ease the burden and fear of seeking testing service. Regular use of healthcare 
services was associated with likelihood of testing (Ford, Godette, Malatu & Gaines 2015; 
Youssef et al. 2017). No need of parental consent for under 18 years and provision of free 
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self-testing kit was outlined in one study as factor that can facilitate timely and frequent ac-
cess to HIV testing among youths (Pharr et al. 2015). 
6 Discussion 
The objective of this study was to seek evidence on factors that contributes to low HIV test-
ing service uptake in Finland, and factors that when put into practice can lead to increased 
HIV testing service uptake. Reviewed literatures confirmed that, there are numerous factors 
that facilitate or act a barrier to HIV testing service uptake. The most common barriers iden-
tified from reviewed studies are lack of perceived HIV risk, lack of knowledge and awareness, 
lack of access to testing, discomfort and communication problem, providers’ time constraint, 
and stigma and fear. Respectively, common identified facilitators are: Integrating HIV ser-
vices and normalizing testing, increasing knowledge and awareness and access to testing. 
Lack of perceived risk to HIV and lack of knowledge and awareness emerged the most dis-
cussed barriers in the reviewed articles (Tan & Black 2018; Traversy et al. 2018; Leblanc et 
al. 2016; Youssef et al. 2017; Beach et al. 2018; Pharr et al. 2015; Mathews et al. 2020; 
Youssef et al. 2017). Lack of perceived risk to HIV was associated with patients/providers at-
titude. Patient perceived that, not engaging in HIV risk behaviours, or believing residing in a 
low prevalence HIV region exempt them from risk of contracting HIV infection (Leblanc et al. 
2016). Healthcare providers assumptions like, risk of acquiring HIV among his/her patients is 
low or do not exist may act as barrier to recommending HIV test to their patients/clients (Le-
blanc et al. 2016; Tan & Black 2018; Traversy et al. 2018). Lack of knowledge and awareness 
about HIV and getting testing for HIV are the greatest barriers to HIV screening. 
 Lacking knowledge about HIV or unaware of how, when, and where to seek testing services 
has a likelihood of leading to a missed/late diagnosis (Mathews et al. 2020; Traversy et al. 
2018). However, providing patient-centred education through different medium to increase 
HIV awareness, may lead improved HIV testing uptake (Tan & Black 2018). Providers lack of 
knowledge about HIV testing recommendations and guidelines, difficulties in using HIV risk in-
dictor tools or not aware of the tools, lack of experience in delivering test results and una-
ware of consent procedure can be associated with low HIV testing uptake (Beach et al. 2018; 
Pharr et al. 2015; Tan & Black 2018; Deblonde et al. 2018; Mathews et al. 2020; Traversy et 
al. 2018; Leblanc et al. 2016; Youssef et al. 2017). However, providing provider-centred train-
ing to equip them with skills to engage clients in discussions about sexual health and skills to 
encourage and reinforce the importance of knowing own’s HIV status is recommended 
(Deblonde et al. 2018; Leblanc et al. 2016; Traversy et al. 2015). 
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Providers’ time constraint and competing priorities were frequently mentioned by health care 
providers as a reason for them not testing. Lack of enough workforce, unfamiliarity with HIV 
testing related procedures may deter offering routine HIV testing (Deblonde et al. 2018; 
Traversy et al. 2015; Youssef et al. 2017; Tan & Black 2018). However, providing enough 
workforce and training health care provider on HIV testing related procedures may facilitate 
them to proactively offer HIV test (Traversy et al. 2015). Inconvenient and limited testing lo-
cations, centralizing testing only in HIV clinics, having to buy HIV self-testing kits and paren-
tal consent for under 18 years may act as barrier to accessing testing services (Traversy et al. 
2015; Leblanc et al. 2016). However, providing favourable and accessible testing service 
point, decentralizing testing services beyond HIV clinics, offering HIV self-testing kits for 
free/subsidized price, no parental consent requirement for under 18 years may encourage pa-
tients/clients to seek HIV testing (Traversy et al. 2015; Leblanc et al. 2016; Tan & Black 
2018). 
Fear and stigma are found to be common barriers to testing. Fear of potential positive result, 
concern of confidentiality/lack of trust for providers, fear of being stigmatized and discrimi-
nated may hinder people from HIV screening (Pharr et al. 2015; Beach et al. 2018). Integrat-
ing HIV testing service into primary healthcare and making screening a routine clinical activity 
may reduce stigma and fear associated with HIV. Also, up-to date and clear flexible policies 
may ease provider reluctancy in offering test (Youssef et al. 2017). 
6.1 Strength and Limitation 
The strength of this study is that it present broad overview of barrier and facilitators to HIV 
testing. Many studies on topic of HIV have been conducted in Finland, but authors did not find 
any study conducted in English focusing entirely on barriers and facilitators to HIV testing ser-
vice uptake in Finland. Therefore, this makes the study the first one of its kind. Articles pub-
lished between 2015 and 2020 were used, thus making the findings of the study more up to 
date. Data from several types of study designs was combined hence increasing the strengths 
of this review. However, only articles published in English language were included in the 
study leading to publication bias. The publication bias may have excluded some evidence 
which may have enhanced the reliability of this study. 
6.2 Ethical consideration 
Since the study was a theoretical one, no ethical approval was required. However, this did 
not exempt the authors from adhering to certain responsibilities crucial when conducting an 
ethical literature review. When conducting and reporting literature reviews, it is most essen-
tial to maintain transparency, maintain accuracy during data extraction, outline potential 
conflict of interest and funding sources, avoid redundant publications and plagiarized materi-
als. (Wager & Wiffen 2011, 130-134). The authors declare no conflict of interest in this study. 
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Since the study was conducted through reviewing past literatures, no funding sources were 
used. To maintain transparency and accuracy during data extraction and reporting, all arti-
cles included were read thoroughly both individually and together to avoid bias in data collec-
tion and reporting. The references of this study were included to avoid plagiarism. Arising dis-
agreements were solved through discussion. 
6.3 Authors’ contribution and acknowledgement 
This integrative literature review was performed as part of the authors’ Master studies in Lau-
rea University of Applied Sciences and both authors contributed equally during the entire 
study process. Both authors were equally responsible for writing the theoretical background 
of the study, where work was divided according to topics. During data search, data review 
and data analysis, both authors contributed equally. Finally, writing results and discussion in-
volved continuous mutual reasoning between both authors and participated equally. 
7 Conclusion and recommendations 
HIV testing is crucial step for prevention and early detection of infection to improve the prog-
nosis of treatment and prevent further transmission. It remains the only means to providing 
early diagnosis to ensure that appropriate treatments are started early for those found to 
have been infected with the virus. This integrative review was conducted to seek evidence on 
barriers and facilitators to HIV testing service uptake in Finland. Therefore, recognizing the 
key barriers and facilitators to HIV testing is essential to increase population testing uptake 
capacity. The findings can be used as a tool to facilitate creation of effective strategies, 
aimed at increasing HIV testing serve uptake and decreasing the number of infected people 
who are unaware of their status. However, there is lack of evidence to what extent the find-
ings are applicable to Finnish setting and therefore more research is needed to verify these 
findings. 
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Appendix 1: Characteristics of included studies 
References  Country Purpose/ aim / 
objectives of the 
study 
Design and study 
sample 
Data and meth-
ods 
Results Quality 
assess-
ment 
Beach et al. 
2018.  
Barriers and Fa-
cilitators to 
Seeking HIV Ser-
vices in Chicago 
Among Young 
Men Who Have 
Sex with Men: 
Perspectives of 
HIV Service Pro-
viders 
 
United States of 
America 
To study barriers 
and facilitators 
HIV service pro-
viders in Chicago 
identified as af-
fecting whether 
YMSM utilized HIV 
treatment and/or 
prevention ser-
vices housed 
within their or-
ganization. 
A qualitative 
study 
Participants: 
34 HIV service 
providers from 20 
different HIV pre-
vention projects 
within 15 organi-
zations in Chicago 
city. 
21 Semi-struc-
tured interviews 
administered to 
34 HIV service 
providers 
Five main conceptual themes cut across 
multiple themes were interpreted, and 
the following barriers and facilitators 
were found: 
Barriers: 
-lack of comprehensive wraparound ser-
vices  
-lack of trust of providers  
-Not knowing how to seek HIV services 
-lack of knowledge of HIV service  
-providers, intersectional and structural 
concerns (e.g. not thinking the site’s 
services were for YMSM),  
-location and distance to clinic 
-HIV stigma. 
Facilitators: 
- presence of comprehensive wrapa-
round services 
- high trust in providers  
-A clinic’s willingness to serve uninsured 
patients 
-Engaging the community 
-Word-of-mouth recommendations from 
lesbian, gay, bisexual, and transgender 
(LGBT) friends 
-Offering LGBT-tailored services  
-Favourable location of service points 
and accessible. 
-lack of HIV stigma. 
18/20 
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Ford et al. 2015. 
Recent HIV Test-
ing Prevalence, 
Determinants, 
and Disparities 
Among US Older 
Adult Respond-
ents to the Be-
havioural Risk 
Factor Surveil-
lance System 
United States of 
America 
To identify the 
factors associated 
with HIV testing 
in the past 12 
months (i.e., 
recent HIV test-
ing) among US 
adults. 
Cross-sectional 
analysis from sur-
vey data 
Participants: 
143,247 adults 
aged between 50-
64 years  
Cross-sectional, 
secondary anal-
ysis of publicly 
available 2010 
BRFSS data from 
all US states 
and the District 
of Columbia  
The findings: 
-low testing rate i.e., 3% had tested for 
HIV in the previous 12 months 
-Saw doctor in the last year 
-high reported risk behaviours 
40/44 
Pharr et al.2015. 
Barriers to HIV 
Testing Among 
Young Men Who 
Have Sex with 
Men (MSM): Ex-
periences from 
Clark County, 
Nevada 
 
United states of 
America 
To identify barri-
ers and facilita-
tors to HIV test-
ing experienced 
by young MSM in 
Clark County, Ne-
vada 
A qualitative 
study 
Participant: 
11 young MSM 
A semi-struc-
tured focus 
group discussion 
conducted in 
March 2015. 
Purposive sam-
pling method 
was used to re-
cruit partici-
pants. Out-
comes were ac-
cessed using 
Thematic con-
tent analysis. 
Themes were 
coded either 
within the per-
son or within 
the environ-
ment. 
 
Barriers: 
1.factors within the person 
-lack of awareness or knowledge 
-fear of positive result, rejection from 
families/community, disclosure to fam-
ily. 
-lack of self-esteem or confidence. 
2.within the environment 
-Access: cost of testing, lack transporta-
tion, lack of phone, wait time for the 
result, parental consent for under 18. 
-Stigma: HIV is a gay disease; gay peo-
ple lack support from community  
-Unfriendly test environments attributed 
to care providers. 
 
Facilitator: 
1.factors within person 
-Fear of having contracted HIV  may re-
sult into testing 
2. within the environment 
-Ability to call information and get loca-
tion of testing centres 
20/20 
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-Ads on local gay publication sites indi-
cating testing locations and cost 
-Mobile testing 
-Availability of rapid HIV testing 
-Friendly test environments 
Tan & Black 
2018. 
A Systematic Re-
view of Health 
Care Provider-
Perceived Barri-
ers and Facilita-
tors to Routine 
HIV Testing in 
Primary Care 
Settings in the 
South-eastern 
United States 
United states of 
America 
To describe 
health care pro-
viders’ perceived 
barriers and facil-
itators to testing 
for HIV at poorly 
used/novel test-
ing sites in the 
south eastern 
United States 
Systematic re-
view 
Research in-
cluded 12 studies 
that were con-
ducted in south 
eastern USA and 
published be-
tween January 
2006- April 2017. 
3 electronic da-
tabases (Em-
base, Medline 
and CINAHL) 
were searched 
for Peer re-
viewed studies 
of providers’ 
perceived barri-
ers and facilita-
tors to routine 
HIV testing from 
January 2006 to 
April 2017 in ac-
cordance to 
PRISMA state-
ment. 
Barriers and facilitators noted were 
group into 3 level: 
Barriers: 
-societal level included lack of financial 
support, stigma, unclear policies, lack 
of resources like testing kits and educa-
tion materials, population characteris-
tics like low perceived HIV risk state, 
poor information flow in health care. 
-Organizational level included clinical 
characteristics such time constraint, 
lack of inconsistent or unaware of 
guidelines, inconvenient referral pro-
cess, administrative/staff problems like 
lack of compliance to guidelines 
-Individual level included  
1. providers’ attitude and prioritization, 
discomfort talking about sexual prac-
tices, lack of knowledge,  
2. Patients’ misconceptions about risks 
for HIV, attitude like fear of positive re-
sults, and lack of education. 
Facilitators: 
-Societal factors included adequate 
funding for HIV programmes, stigma re-
duction through social marketing, up-to 
date and clear  flexible policies, enough 
resources for education and testing pur-
poses, public campaigns to increase 
19/20 
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population HIV awareness, streamline 
HIV counselling. 
-Organizational factors included allocat-
ing enough time, integrating HIV ser-
vices into routine clinical activities, Im-
proved internal and external referral 
networks, Improvement in administra-
tion. 
-Individual factors included 
1. Providers’ positive attitude and  pri-
oritization of HIV service care, harmoni-
ous relationship with patients, Sufficient 
training, and knowledge on HIV. 
2. Individuals risk awareness of HIV, pos-
itive attitude towards HIV and willing-
ness to seek services, education on HIV. 
Aung et al. 2017. 
Interventions for 
Increasing HIV 
Testing Uptake 
in Migrants: 
A Systematic Re-
view of Evidence 
 
Australia To review and 
evaluate inter-
ventions that aim 
to increase HIV 
testing uptake in 
migrant popula-
tions 
Systematic re-
view. 
 
Research in-
cluded 10 studies 
on international 
migrants, con-
ducted in USA, 
Australia, Europe, 
and other high-in-
come countries. 
 
Five databases 
(PubMed, Web 
of Science, Em-
base, CINAHL, 
and PsycInfo) 
were searched 
for studies pub-
lished between 
January 1985 
and 31 Decem-
ber 
2016. 
The outcomes were grouped in three 
categories: 
1.Exposure to HIV preventions messages 
such as importance of condom use and 
getting HIV test through media plat-
form.  
 
2.Interactive HIV education program 
 
3.Direct offer of HIV testing 
 
20/20 
Deblonde et al. 
2018. 
HIV testing 
within general 
practices in 
Europe To synthesis and 
diffuse existing 
evidence to fur-
ther promote HIV 
testing in primary 
care 
Mixed method 
systematic re-
view. 
Research in-
cluded 29 studies 
on HIV testing on 
In May 2017 
three databases 
(PubMed, Sco-
pus and 
Embase) were 
searched for 
studies 
Barriers: 
-Poor communication skills on sexual 
health.  
-lack of knowledge about HIV testing 
recommendations 
-Lack of time  
20/20 
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Europe: a mixed-
methods system-
atic 
Review 
settings, to de-
sign new inter-
ventions and to 
increase the util-
ity of the availa-
ble research  
general practices 
in Europe. 
 
 
published be-
tween 2006-
2017 on HIV 
testing in gen-
eral practices in 
Europe  
-Difficulties with using the complete list 
of clinical HIV indicator diseases  
-lack of experience in delivering test re-
sults 
Facilitators: 
-provision of specific 
training  
-Availability of practical tools to calcu-
late HIV risk score  
-promotion programmes 
Leblanc et al. 
2016. 
Facilitators and 
Barriers to HIV 
Screening: A 
Qualitative Meta-
Synthesis 
United states of 
America 
To identify quali-
tative studies 
that addressed 
what 
influences people 
to screen for HIV 
infection and  
receive their re-
sults? 
A Qualitative 
Meta-Synthesis. 
Research in-
cluded 128 quali-
tative studies 
conducted glob-
ally. 
Three databases 
(CINAHL, MED-
LINE and 
PsycINFO) were 
searched be-
tween January 
2008- December 
2013 on HIV 
screening and 
receipt of re-
sults 
Barriers: 
-Fear of positive result 
-Lack of knowledge of where to get 
tested 
-Lack of awareness 
-Lack of risk perception 
-Being in a long relationship 
-providers lack communication and in-
terpersonal skills 
-Inconvenient testing locations 
Facilitators: 
-Improved strategies to test 
-Choice of services 
-Integrating HIV testing in primary 
healthcare 
-Alleviate fear of positive result through 
community-based support groups which 
address HIV stigma issues 
- Education on HIV 
-Increase healthcare provider capacity 
- Holistic targeting of services 
14/20 
Mathews et al. 
2020. 
Meet people 
where they 
United states of 
America 
To identify com-
munity-based 
strategies to in-
crease testing 
Qualitative study 
Participants: 
52 men and 
women between 
A community-
based participa-
tory research 
principle, 
Barriers: 
-Concerns on confidentiality  
-Unpleasant treatments by care provid-
ers 
20/20 
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are”: a qualita-
tive study of 
community bar-
riers and facilita-
tors to HIV test-
ing and HIV self-
testing among 
African Ameri-
cans in urban 
and rural areas 
in North Carolina 
among African 
Americans in both 
urban and rural 
areas 
15 to 60 years old 
living in urban 
(n=41) and rural 
(n=11) areas of 
North Carolina. 
conducted using  
focus group dis-
cussions among 
highly affected 
(i.e., PLWH, 
MSM, PWID, 
low-income, 
teens and young 
adults) popula-
tions from Afri-
can American 
communities in 
North Carolina. 
-Lack of knowledge on self-testing kit 
usage. 
-Lack of post-test support 
Facilitators 
-partnering with community leaders. 
-decentralizing testing beyond facility-
based sites.  
-protecting confidentiality 
 
Traversy et al. 
2015 
An overview of 
recent evidence 
on barriers and 
facilitators to 
HIV testing 
Canada  To summarize 
the most recent 
evidence regard-
ing barriers and 
facilitators to HIV 
testing, to ex-
pand upon the re-
search conducted 
for the HIV 
Screening and 
Testing Guide. 
A literature re-
views. 
Research in-
cluded 34 studies 
and reports from 
Canada, the 
United States, 
Europe, Australia, 
and New Zealand, 
published be-
tween 2010 and 
2014. 
 
Data was ex-
tracted from 
Scopus, PubMed 
(MEDLINE) data-
bases and web-
sites  of  CDC, 
the ECDC, the 
Australian De-
partment of 
Health, and the 
New Zealand 
Ministry of 
Health.  
Barriers: 
-Fear, stigma, and discrimination 
-lack of perceived risk of HIV 
-Lack of knowledge about HIV and lack 
comfort discussing about HIV 
- Healthcare providers lack time 
- A lack of ability to access testing 
-Financial and human resources con-
straints 
Facilitators: 
-Increasing knowledge and awareness 
-Opt-out testing 
-Normalizing HIV testing 
16/20 
Youssef et al. 
2017. 
Barriers and fa-
cilitators to HIV 
testing in people 
age 50 and 
above: a system-
atic review 
United Kingdom To identify pa-
tient and clini-
cian-related bar-
riers/facilitators 
to HIV testing in 
people aged ≥50 
years 
systematic review 
Research in-
cluded 17 studies 
conducted within 
USA 
(n=14),  UK (n=1), 
Brazil (n=1) and 
Uganda (n=1) 
Data was 
searched from  
MEDLINE, Em-
base, Psych-
INFO, CINAHL 
and 
the Cochrane li-
brary databases  
on 7th April 
Barriers: 
-Low perceived risk 
-Clinicians preconception about older 
people (e.g. have minimal risk). 
-stigma 
-Being asymptomatic or symptoms not 
associated with HIV 
-Fear of positive result 
- Physicians’ time constraint 
20/20 
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2017. Relevant 
conference ab-
stracts were 
also included. 
Data was the-
matically ana-
lysed 
-Healthcare providers not suggesting HIV 
test to the patients. 
- Clinician uncomfortable discussing  
Sexuality of older patients 
Facilitators 
- regular use of healthcare services  
-Being offered/encouraged to test by 
a healthcare provider 
-Previous HIV test 
-Including HIV testing in general routine 
check-up. 
- High actual/perceived risk 
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Appendix 2: Quality assessment of qualitative studies applied from CASP(A) 
References 
 
1 2 3 4 5 6 7 8 9 10 Score 
Max = 20 
Beach et al. 
2018 
2 2 2 2 2 2 0 2 2 2 18/20 
Pharr et 
al.2015. 
2 2 2 2 2 2 2 2 2 2 20/20 
Leblanc et 
al.2016. 
2 2 2 0 2 0 1 1 2 2 14/20 
Mathews et 
al. 2020. 
2 2 2 2 2 2 2 2 2 2 20/20 
 
1. Aim of the study are clearly stated 
2. Qualitative methodology is appropriate 
3. Research design is appropriate to address the aims of the research 
4. Recruitment strategy is appropriate to the aims of the research 
5. The data is collected in a way that it addresses the research issue 
6. The relationship between researcher and participants are adequately considered 
7. Ethical issues have been taken into consideration 
8. The data analysis is sufficiently rigorous 
9. The findings are clearly stated 
10. The value of the research is discussed 
 
Scores: 0 = No, 1= Partially, 2= Yes 
36 
 
 
Appendix 3: Quality assessment of systematic reviews studies applied from CASP(B) 
References 1 2 3 4 5 6 7 8 9 10 Score 
Max = 20 
Tan & Black 
2018. 
2 2 2 1 2 2 2 2 2 2 19/20 
Aung et al. 
2017. 
2 2 2 2 2 2 2 2 2 2 20/20 
Deblonde 
et al. 2018. 
2 2 2 2 2 2 2 2 2 2 20/20 
Traversy et 
al. 2015. 
2 1 2 0 2 2 2 1 2 2 16/20 
Youssef et 
al. 2017. 
2 2 2 2 2 2 2 2 2 2 20/20 
 
1. The review addressed a clear focused question 
2. The author chose the right type of papers 
3. All the important relevant studies were included 
4. The review’s authors did enough to assess the quality of included studies 
5. It was reasonable to combine the results of the review (in case are combined). 
6. The overall results of the review 
7. Results are precise 
8. Results can be applied to local population 
9. Important outcomes were considered  
10. Benefits are worthy the harms and costs 
Scores: 0 = No, 1= Partially, 2= Yes 
37 
 
 
Appendix 4: Quality assessment of cross-sectional analysis survey applied from STROBE statement (C) 
Reference 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Score 
Max=44 
Ford et al. 
2015. 
2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 0 40/44 
 
1. Study design, title and abstract are defined    14. Descriptive data is explained 
2. Background of the study is explained   15. Outcome data is reported 
3. Objectives are stated    16. Main results are reported 
4. Study design key elements are presented    17. Other analyses are reported 
5. Study settings are described     18. Key results are summarised 
6. Eligibility criteria of the participants are described   19. Study limitations are discussed 
7. Variables are defined     20. Interpretation is explained 
8. Data sources/measurement are defined    21. Generalisability is discussed 
9. Bias are portrayed     22. Funding is reported 
10. Study size is explained 
11. Quantitative variables are explained 
12. Statistical methods are described 
13. Number of participants is well explained and reported 
 
Scores: 0 = No, 1= Partially, 2= Yes 
 
